Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages

Oncolytic viruses (OVs) for cancer treatment are in a rapid stage of development, and the direct tumor lysis and activation of a comprehensive host immune response are irreplaceable advantages of cancer immunotherapy. However, excessive antiviral immune responses also restrict the spread of OVs in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Zhen, Liu, Xiyu, Fan, Guixiang, Na, Jintong, Liu, Qiaoqiao, Lin, Faquan, Zhang, Zhikun, Zhong, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666393/
https://www.ncbi.nlm.nih.gov/pubmed/37993941
http://dx.doi.org/10.1186/s12967-023-04709-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666393/
https://www.ncbi.nlm.nih.gov/pubmed/37993941
http://dx.doi.org/10.1186/s12967-023-04709-z

Ejemplares similares